Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Dextran sodium sulfate (DSS) induces necrotizing enterocolitis-like lesions in neonatal mice.

Ginzel M, Feng X, Kuebler JF, Klemann C, Yu Y, von Wasielewski R, Park JK, Hornef MW, Vieten G, Ure BM, Kaussen T, Gosemann JH, Mayer S, Suttkus A, Lacher M.

PLoS One. 2017 Aug 17;12(8):e0182732. doi: 10.1371/journal.pone.0182732. eCollection 2017.

2.

Quality assurance trials for Ki67 assessment in pathology.

Raap M, Ließem S, Rüschoff J, Fisseler-Eckhoff A, Reiner A, Dirnhofer S, von Wasielewski R, Kreipe H.

Virchows Arch. 2017 Oct;471(4):501-508. doi: 10.1007/s00428-017-2142-y. Epub 2017 May 11.

PMID:
28497316
3.

An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.

Varga Z, Lebeau A, Bu H, Hartmann A, Penault-Llorca F, Guerini-Rocco E, Schraml P, Symmans F, Stoehr R, Teng X, Turzynski A, von Wasielewski R, Gürtler C, Laible M, Schlombs K, Joensuu H, Keller T, Sinn P, Sahin U, Bartlett J, Viale G.

Breast Cancer Res. 2017 May 11;19(1):55. doi: 10.1186/s13058-017-0848-z.

4.

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.

Iftner T, Wang L, Iftner A, Holz B, Haedicke-Jarboui J, Iftner N, von Wasielewski R, Martus P, Boehmer G.

BMC Infect Dis. 2016 Nov 11;16(1):672.

5.

The viral dsRNA analogue poly (I:C) induces necrotizing enterocolitis in neonatal mice.

Ginzel M, Yu Y, Klemann C, Feng X, von Wasielewski R, Park JK, Hornef MW, Torow N, Vieten G, Ure BM, Kuebler JF, Lacher M.

Pediatr Res. 2016 Apr;79(4):596-602. doi: 10.1038/pr.2015.261. Epub 2015 Dec 17.

PMID:
26679153
6.

CIN III lesions and regression: retrospective analysis of 635 cases.

Motamedi M, Böhmer G, Neumann HH, von Wasielewski R.

BMC Infect Dis. 2015 Nov 21;15:541. doi: 10.1186/s12879-015-1277-1.

7.

HPV16 RNA patterns defined by novel high-throughput RT-qPCR as triage marker in HPV-based cervical cancer precursor screening.

Höfler D, Böhmer G, von Wasielewski R, Neumann H, Halec G, Holzinger D, Dondog B, Gissmann L, Pawlita M, Schmitt M.

Gynecol Oncol. 2015 Sep;138(3):676-82. doi: 10.1016/j.ygyno.2015.06.039. Epub 2015 Jul 3.

PMID:
26148764
8.

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.

Boehmer G, Wang L, Iftner A, Holz B, Haedicke J, von Wasielewski R, Martus P, Iftner T.

BMC Infect Dis. 2014 Dec 9;14:674. doi: 10.1186/s12879-014-0674-1.

9.

Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues.

Kollecker I, von Wasielewski R, Langner C, Müller JA, Spitzweg C, Kreipe H, Brabant G.

Thyroid. 2012 May;22(5):529-35. doi: 10.1089/thy.2011.0311.

PMID:
22545753
10.

The impact of deep and moderate body temperatures on end-organ function during hypothermic circulatory arrest.

Khaladj N, Peterss S, Pichlmaier M, Shrestha M, von Wasielewski R, Hoy L, Haverich A, Hagl C.

Eur J Cardiothorac Surg. 2011 Dec;40(6):1492-9; discussion 1499. doi: 10.1016/j.ejcts.2011.03.031. Epub 2011 Apr 30.

PMID:
21531569
11.

Hypothermic circulatory arrest with "low flow" lower body perfusion: an experimental feasibility study of microcirculatory parameters.

Peterss S, Khaladj N, Pichlmaier M, Hoeffler K, von Wasielewski R, Shrestha ML, Haverich A, Hagl C.

Thorac Cardiovasc Surg. 2011 Sep;59(6):335-41. doi: 10.1055/s-0030-1250727. Epub 2011 Mar 21.

PMID:
21425052
12.

Rise and fall of an anti-MUC1 specific antibody.

Thie H, Toleikis L, Li J, von Wasielewski R, Bastert G, Schirrmann T, Esteves IT, Behrens CK, Fournes B, Fournier N, de Romeuf C, Hust M, Dübel S.

PLoS One. 2011 Jan 14;6(1):e15921. doi: 10.1371/journal.pone.0015921.

13.

Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.

Burrows N, Resch J, Cowen RL, von Wasielewski R, Hoang-Vu C, West CM, Williams KJ, Brabant G.

Endocr Relat Cancer. 2010 Jan 29;17(1):61-72. doi: 10.1677/ERC-08-0251. Print 2010 Mar.

14.

Comparison of different tissue sampling methods for protein extraction from formalin-fixed and paraffin-embedded tissue specimens.

Gräntzdörffer I, Yumlu S, Gioeva Z, von Wasielewski R, Ebert MP, Röcken C.

Exp Mol Pathol. 2010 Feb;88(1):190-6. doi: 10.1016/j.yexmp.2009.09.009. Epub 2009 Sep 24.

PMID:
19782068
15.

Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma.

Zhao F, Obermann S, von Wasielewski R, Haile L, Manns MP, Korangy F, Greten TF.

Immunology. 2009 Sep;128(1):141-9. doi: 10.1111/j.1365-2567.2009.03105.x.

16.

[Predictive parameters in children with biliary atresia].

Leonhardt J, Kuebler JF, Turowski C, von Wasielewski R, Pfister ED, Becker T, Ure BM, Petersen C.

Chirurg. 2009 Jul;80(7):628-33. doi: 10.1007/s00104-009-1708-x. German.

PMID:
19352604
17.

Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents.

Liebrich C, Brummer O, Von Wasielewski R, Wegener G, Meijer C, Iftner T, Petry KU.

Eur J Gynaecol Oncol. 2009;30(1):45-8.

PMID:
19317256
18.

Expression and secretion of endostatin in thyroid cancer.

Hoffmann S, Wunderlich A, Lingelbach S, Musholt PB, Musholt TJ, von Wasielewski R, Zielke A.

Ann Surg Oncol. 2008 Dec;15(12):3601-8. doi: 10.1245/s10434-008-0170-1. Epub 2008 Sep 26.

PMID:
18818971
19.

Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.

Haile LA, von Wasielewski R, Gamrekelashvili J, Krüger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF.

Gastroenterology. 2008 Sep;135(3):871-81, 881.e1-5. doi: 10.1053/j.gastro.2008.06.032. Epub 2008 Jun 12.

PMID:
18674538
20.

[Interlaboratory trials for quality assurance of breast cancer biomarkers in Germany].

Krusche CA, von Wasielewski R, Rüschoff J, Fisseler-Eckhoff A, Kreipe HH.

Pathologe. 2008 Jul;29(4):315-20. doi: 10.1007/s00292-008-1004-4. German.

PMID:
18504581
21.

TSPY expression is variably altered in transgenic mice with testicular feminization.

Schubert S, Kamino K, Böhm D, Adham I, Engel W, von Wasielewski R, Moharregh-Khiabani D, Mauceri G, Vaske B, Meinhardt A, Schöner A, Gonzalez-Fassrainer D, Schmidtke J.

Biol Reprod. 2008 Jul;79(1):125-33. doi: 10.1095/biolreprod.107.067025. Epub 2008 Apr 9.

PMID:
18401008
22.

Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver injury.

Lamlé J, Marhenke S, Borlak J, von Wasielewski R, Eriksson CJ, Geffers R, Manns MP, Yamamoto M, Vogel A.

Gastroenterology. 2008 Apr;134(4):1159-68. doi: 10.1053/j.gastro.2008.01.011. Epub 2008 Jan 11.

PMID:
18395094
23.

CO(2) pneumoperitoneum increases systemic but not local tumor spread after intraperitoneal murine neuroblastoma spillage in mice.

Metzelder M, Kuebler J, Shimotakahara A, Vieten G, von Wasielewski R, Ure BM.

Surg Endosc. 2008 Dec;22(12):2648-53. doi: 10.1007/s00464-008-9778-2. Epub 2008 Feb 13.

PMID:
18270765
24.

Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany.

von Wasielewski R, Krusche CA, Rüschoff J, Fisseler-Eckhoff A, Kreipe H.

Breast Care (Basel). 2008;3(2):128-133. Epub 2008 Apr 15.

25.

Serial sectioning and three-dimensional reconstruction of mouse Peyer's patch.

Ma B, Wang L, von Wasielewski R, Lindenmaier W, Dittmar KE.

Micron. 2008 Oct;39(7):967-75. Epub 2007 Oct 22.

PMID:
18037303
26.

[Tissue-based markers of prognosis in breast cancer].

Kreipe H, von Wasielewski R.

Verh Dtsch Ges Pathol. 2005;89:52-8. German.

PMID:
18035673
27.

Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.

Bleich A, Sundberg JP, Smoczek A, von Wasielewski R, de Buhr MF, Janus LM, Julga G, Ukena SN, Hedrich HJ, Gunzer F.

Int J Exp Pathol. 2008 Feb;89(1):45-54. Epub 2007 Nov 13.

28.

Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.

Christgen M, Ballmaier M, Bruchhardt H, von Wasielewski R, Kreipe H, Lehmann U.

Mol Cell Biochem. 2007 Dec;306(1-2):201-12. Epub 2007 Jul 28.

PMID:
17660947
29.

Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts.

Imkamp F, von Wasielewski R, Musholt TJ, Musholt PB.

J Surg Res. 2007 Dec;143(2):350-63. Epub 2007 Jul 26.

PMID:
17655865
30.

Beyond typing and grading: target analysis in individualized therapy as a new challenge for tumour pathology.

Kreipe HH, von Wasielewski R.

Recent Results Cancer Res. 2007;176:3-6.

PMID:
17607911
31.

Immunocytological detection of lymph node metastases in dogs with malignant epithelial tumours.

Höinghaus R, von Wasielewski R, Hewicker-Trautwein M, Freund M, Mischke R.

J Comp Pathol. 2007 Jul;137(1):1-8. doi: 10.1016/j.jcpa.2007.02.004. Epub 2007 May 31.

PMID:
17543325
32.

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer.

Gaedcke J, Traub F, Milde S, Wilkens L, Stan A, Ostertag H, Christgen M, von Wasielewski R, Kreipe HH.

Mod Pathol. 2007 Aug;20(8):864-70. Epub 2007 Jun 1.

33.

Immmunohistochemical study of the blood and lymphatic vasculature and the innervation of mouse gut and gut-associated lymphoid tissue.

Ma B, von Wasielewski R, Lindenmaier W, Dittmar KE.

Anat Histol Embryol. 2007 Feb;36(1):62-74.

PMID:
17266671
34.

Necrotic tumor cell death in vivo impairs tumor-specific immune responses.

Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, Manns MP, Korangy F, Greten TF.

J Immunol. 2007 Feb 1;178(3):1573-80.

35.

Legumain expression as a prognostic factor in breast cancer patients.

Gawenda J, Traub F, Lück HJ, Kreipe H, von Wasielewski R.

Breast Cancer Res Treat. 2007 Mar;102(1):1-6. Epub 2006 Sep 21.

PMID:
17028987
36.

p16INK4a expression and clinicopathologic parameters in renal cell carcinoma.

Ikuerowo SO, Kuczyk MA, von Wasielewski R, Shittu OB, Jonas U, Machtens S, Serth J.

Eur Urol. 2007 Mar;51(3):732-7; discussion 738. Epub 2006 Aug 23.

PMID:
16949731
37.

[Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].

von Wasielewski R, Klöpper K, Lück HJ, Kreipe H.

Pathologe. 2006 Sep;27(5):337-45. German.

PMID:
16896675
38.

[25 years of the German Study Group of Hodgkin's Disease--a successful cooperation of pathologists and clinicians].

Diehl V, von Wasielewski R.

Verh Dtsch Ges Pathol. 2003;87:58-65. German. No abstract available.

PMID:
16888895
39.

Hypothermic circulatory arrest with moderate, deep or profound hypothermic selective antegrade cerebral perfusion: which temperature provides best brain protection?

Khaladj N, Peterss S, Oetjen P, von Wasielewski R, Hauschild G, Karck M, Haverich A, Hagl C.

Eur J Cardiothorac Surg. 2006 Sep;30(3):492-8. Epub 2006 Jul 20.

PMID:
16857368
40.

[The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas].

Länger F, von Wasielewski R, Kreipe HH.

Pathologe. 2006 Jul;27(4):244-50. Review. German.

PMID:
16758167
41.

Prognostic impact of Skp2 and p27 in human breast cancer.

Traub F, Mengel M, Lück HJ, Kreipe HH, von Wasielewski R.

Breast Cancer Res Treat. 2006 Sep;99(2):185-91. Epub 2006 Apr 25.

PMID:
16636894
42.

Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.

Kersting C, Packeisen J, Leidinger B, Brandt B, von Wasielewski R, Winkelmann W, van Diest PJ, Gosheger G, Buerger H.

J Clin Pathol. 2006 Jun;59(6):585-90. Epub 2006 Feb 3.

43.

Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.

Garbe AI, Vermeer B, Gamrekelashvili J, von Wasielewski R, Greten FR, Westendorf AM, Buer J, Schmid RM, Manns MP, Korangy F, Greten TF.

Cancer Res. 2006 Jan 1;66(1):508-16.

44.

Gene expression profile of the infective murine model for biliary atresia.

Leonhardt J, Stanulla M, von Wasielewski R, Skokowa J, Kübler J, Ure BM, Petersen C.

Pediatr Surg Int. 2006 Jan;22(1):84-9.

PMID:
16328331
45.

Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer.

Rao AS, Kremenevskaja N, von Wasielewski R, Jakubcakova V, Kant S, Resch J, Brabant G.

J Clin Endocrinol Metab. 2006 Jan;91(1):159-68. Epub 2005 Nov 1. Retraction in: J Clin Endocrinol Metab. 2006 Jun;91(6):2118.

PMID:
16263821
46.

Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1.

Musholt TJ, Brehm C, Hanack J, von Wasielewski R, Musholt PB.

J Surg Res. 2006 Mar;131(1):15-25. Epub 2005 Oct 26.

PMID:
16256137
47.

Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.

Hesse E, Musholt PB, Potter E, Petrich T, Wehmeier M, von Wasielewski R, Lichtinghagen R, Musholt TJ.

Br J Cancer. 2005 Sep 5;93(5):565-70.

48.

Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression analysis by mRNA differential display.

Musholt TJ, Hanack J, Brehm C, von Wasielewski R, Musholt PB.

World J Surg. 2005 Apr;29(4):472-82.

PMID:
15776290
49.

Wnt-5a has tumor suppressor activity in thyroid carcinoma.

Kremenevskaja N, von Wasielewski R, Rao AS, Schöfl C, Andersson T, Brabant G.

Oncogene. 2005 Mar 24;24(13):2144-54.

PMID:
15735754
50.

Supplemental Content

Loading ...
Support Center